• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

抑制性和非抑制性 MMP-9-TIMP-1 复合物的结构特征及其对 MMP-9 调控机制的影响。

Structural characterisation of inhibitory and non-inhibitory MMP-9-TIMP-1 complexes and implications for regulatory mechanisms of MMP-9.

机构信息

Department of Biophysics, Faculty of Physics, University of Warsaw, Pasteura 5, 02-093, Warsaw, Poland.

出版信息

Sci Rep. 2021 Jun 28;11(1):13376. doi: 10.1038/s41598-021-92881-x.

DOI:10.1038/s41598-021-92881-x
PMID:34183752
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8238946/
Abstract

MMP-9 plays a number of important physiological functions but is also responsible for many pathological processes, including cancer invasion, metastasis, and angiogenesis. It is, therefore, crucial to understand its enzymatic activity, including activation and inhibition mechanisms. This enzyme may also be partially involved in the "cytokine storm" that is characteristic of COVID-19 disease (SARS-CoV-2), as well as in the molecular mechanisms responsible for lung fibrosis. Due to the variety of processing pathways involving MMP-9 in biological systems and its uniqueness due to the O-glycosylated domain (OGD) and fibronectin-like (FBN) domain, specific interactions with its natural TIMP-1 inhibitor should be carefully studied, because they differ significantly from other homologous systems. In particular, earlier experimental studies have indicated that the newly characterised circular form of a proMMP-9 homotrimer exhibits stronger binding properties to TIMP-1 compared to its monomeric form. However, molecular structures of the complexes and the binding mechanisms remain unknown. The purpose of this study is to fill in the gaps in knowledge. Molecular modelling methods are applied to build the inhibitory and non-inhibitory MMP-9-TIMP-1 complexes, which allows for a detailed description of these structures and should allow for a better understanding of the regulatory processes in which MMP-9 is involved.

摘要

基质金属蛋白酶 9(MMP-9)在许多生理过程中发挥着重要作用,但同时也与许多病理过程有关,包括癌症侵袭、转移和血管生成。因此,了解其酶活性,包括激活和抑制机制,是至关重要的。这种酶可能也部分参与了 COVID-19 疾病(SARS-CoV-2)的“细胞因子风暴”,以及导致肺纤维化的分子机制。由于 MMP-9 在生物系统中涉及多种加工途径,并且由于其 O-糖基化结构域(OGD)和纤维连接蛋白样结构域(FBN)的独特性,与天然 TIMP-1 抑制剂的特异性相互作用应该仔细研究,因为它们与其他同源系统有很大的不同。特别是,早期的实验研究表明,与单体形式相比,新表征的 proMMP-9 三聚体的环状形式对 TIMP-1 表现出更强的结合特性。然而,复合物的分子结构和结合机制仍然未知。本研究的目的是填补知识空白。应用分子建模方法构建抑制性和非抑制性 MMP-9-TIMP-1 复合物,这使得对这些结构进行详细描述成为可能,并应该有助于更好地理解 MMP-9 参与的调节过程。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0f9f/8238946/063e43b47343/41598_2021_92881_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0f9f/8238946/e192b0eb1834/41598_2021_92881_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0f9f/8238946/be130c5eb2bf/41598_2021_92881_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0f9f/8238946/063e43b47343/41598_2021_92881_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0f9f/8238946/e192b0eb1834/41598_2021_92881_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0f9f/8238946/be130c5eb2bf/41598_2021_92881_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0f9f/8238946/063e43b47343/41598_2021_92881_Fig3_HTML.jpg

相似文献

1
Structural characterisation of inhibitory and non-inhibitory MMP-9-TIMP-1 complexes and implications for regulatory mechanisms of MMP-9.抑制性和非抑制性 MMP-9-TIMP-1 复合物的结构特征及其对 MMP-9 调控机制的影响。
Sci Rep. 2021 Jun 28;11(1):13376. doi: 10.1038/s41598-021-92881-x.
2
Identification of a novel 82 kDa proMMP-9 species associated with the surface of leukaemic cells: (auto-)catalytic activation and resistance to inhibition by TIMP-1.鉴定一种与白血病细胞表面相关的新型82 kDa前基质金属蛋白酶-9:(自)催化激活及对金属蛋白酶组织抑制因子-1抑制作用的抗性
Biochem J. 2007 Aug 1;405(3):547-58. doi: 10.1042/BJ20070191.
3
Neutrophil MMP-9 proenzyme, unencumbered by TIMP-1, undergoes efficient activation in vivo and catalytically induces angiogenesis via a basic fibroblast growth factor (FGF-2)/FGFR-2 pathway.不受基质金属蛋白酶组织抑制因子-1(TIMP-1)束缚的中性粒细胞基质金属蛋白酶-9(MMP-9)前酶在体内能有效激活,并通过碱性成纤维细胞生长因子(FGF-2)/成纤维细胞生长因子受体-2(FGFR-2)途径催化诱导血管生成。
J Biol Chem. 2009 Sep 18;284(38):25854-66. doi: 10.1074/jbc.M109.033472. Epub 2009 Jul 16.
4
Circular trimers of gelatinase B/matrix metalloproteinase-9 constitute a distinct population of functional enzyme molecules differentially regulated by tissue inhibitor of metalloproteinases-1.明胶酶B/基质金属蛋白酶-9的环状三聚体构成了一个独特的功能性酶分子群体,其受到金属蛋白酶组织抑制剂-1的不同调节。
Biochem J. 2015 Jan 15;465(2):259-70. doi: 10.1042/BJ20140418.
5
Decreased homodimerization and increased TIMP-1 complexation of uteroplacental and uterine arterial matrix metalloproteinase-9 during hypertension-in-pregnancy.妊娠期高血压期间子宫胎盘和子宫动脉基质金属蛋白酶-9的同源二聚化减少及与金属蛋白酶组织抑制因子-1(TIMP-1)的复合增加。
Biochem Pharmacol. 2017 Aug 15;138:81-95. doi: 10.1016/j.bcp.2017.05.005. Epub 2017 May 12.
6
The effects of Candida proteinases on human proMMP-9, TIMP-1 and TIMP-2.白色念珠菌蛋白酶对人 proMMP-9、TIMP-1 和 TIMP-2 的影响。
Mycoses. 2011 Jul;54(4):325-30. doi: 10.1111/j.1439-0507.2010.01889.x. Epub 2010 Apr 6.
7
Characterization of the monomeric and dimeric forms of latent and active matrix metalloproteinase-9. Differential rates for activation by stromelysin 1.潜伏型和活性基质金属蛋白酶-9的单体和二聚体形式的表征。基质溶解素1激活的不同速率。
J Biol Chem. 2000 Jan 28;275(4):2661-8. doi: 10.1074/jbc.275.4.2661.
8
TIMP-1 binding to proMMP-9/CD44 complex localized at the cell surface promotes erythroid cell survival.与定位于细胞表面的前基质金属蛋白酶-9/CD44复合物结合的基质金属蛋白酶组织抑制因子-1可促进红细胞存活。
Int J Biochem Cell Biol. 2009 May;41(5):1102-15. doi: 10.1016/j.biocel.2008.10.017. Epub 2008 Oct 25.
9
Human neutrophils uniquely release TIMP-free MMP-9 to provide a potent catalytic stimulator of angiogenesis.人类中性粒细胞独特地释放无组织金属蛋白酶抑制因子的基质金属蛋白酶-9,以提供一种强大的血管生成催化刺激物。
Proc Natl Acad Sci U S A. 2007 Dec 18;104(51):20262-7. doi: 10.1073/pnas.0706438104. Epub 2007 Dec 11.
10
Constraining specificity in the N-domain of tissue inhibitor of metalloproteinases-1; gelatinase-selective inhibitors.限制金属蛋白酶组织抑制剂-1 N 结构域的特异性;明胶酶选择性抑制剂
Protein Sci. 2007 Sep;16(9):1905-13. doi: 10.1110/ps.072978507. Epub 2007 Jul 27.

引用本文的文献

1
Shaping Orthodontics of the Future: Concepts and Implications from a Cellular and Molecular Perspective.塑造未来的正畸学:从细胞和分子角度看概念与影响
Int J Mol Sci. 2025 Aug 23;26(17):8203. doi: 10.3390/ijms26178203.
2
Directed evolution of metalloproteinase inhibitor TIMP-1 for selective inhibition of MMP-9 exploits catalytic and fibronectin domain interactions.金属蛋白酶抑制剂TIMP-1的定向进化用于选择性抑制MMP-9,利用了催化结构域和纤连蛋白结构域之间的相互作用。
J Biol Chem. 2025 May 21;301(6):110258. doi: 10.1016/j.jbc.2025.110258.
3
The Effect of Tissue Inhibitor of Metalloproteinases on Scar Formation after Spinal Cord Injury.

本文引用的文献

1
Targeting MMP-Regulation of Inflammation to Increase Metabolic Tolerance to COVID-19 Pathologies: A Hypothesis.针对 MMP 调节炎症以提高对 COVID-19 病理的代谢耐受性:一个假说。
Biomolecules. 2021 Mar 6;11(3):390. doi: 10.3390/biom11030390.
2
Expression of Matrix Metalloproteinase-2, Matrix Metalloproteinase-9, Tissue Inhibitor of Metalloproteinase-1, and Changes in Alveolar Septa in Patients with Chronic Obstructive Pulmonary Disease.慢性阻塞性肺疾病患者基质金属蛋白酶-2、基质金属蛋白酶-9、金属蛋白酶组织抑制剂-1的表达及肺泡间隔变化
Med Sci Monit. 2020 Oct 18;26:e925278. doi: 10.12659/MSM.925278.
3
Cytokine Storm in COVID-19: The Current Evidence and Treatment Strategies.
组织金属蛋白酶抑制剂对脊髓损伤后瘢痕形成的影响。
Cells. 2024 Sep 14;13(18):1547. doi: 10.3390/cells13181547.
4
Advances in the Immunology of the Host-Parasite Interactions in African Trypanosomosis, including Single-Cell Transcriptomics.非洲锥虫病宿主-寄生虫相互作用的免疫学进展,包括单细胞转录组学
Pathogens. 2024 Feb 20;13(3):188. doi: 10.3390/pathogens13030188.
5
Matrix Metalloproteinases in the Periodontium-Vital in Tissue Turnover and Unfortunate in Periodontitis.牙周组织中的基质金属蛋白酶——在组织更新中至关重要,在牙周炎中却有害
Int J Mol Sci. 2024 Feb 27;25(5):2763. doi: 10.3390/ijms25052763.
6
Mitochondrial-targeted antioxidant attenuates preeclampsia-like phenotypes induced by syncytiotrophoblast-specific Gαq signaling.线粒体靶向抗氧化剂减轻合胞体滋养层特异性 Gαq 信号诱导的子痫前期样表型。
Sci Adv. 2023 Dec;9(48):eadg8118. doi: 10.1126/sciadv.adg8118. Epub 2023 Dec 1.
7
Role of thioredoxin in chronic obstructive pulmonary disease (COPD): a promising future target.硫氧还蛋白在慢性阻塞性肺疾病(COPD)中的作用:一个有前途的未来靶点。
Respir Res. 2023 Nov 24;24(1):295. doi: 10.1186/s12931-023-02574-4.
8
Elevated matrix metalloproteinase‑9 expression is associated with COVID‑19 severity: A meta‑analysis.基质金属蛋白酶-9表达升高与新型冠状病毒肺炎严重程度相关:一项荟萃分析。
Exp Ther Med. 2023 Oct 9;26(6):545. doi: 10.3892/etm.2023.12244. eCollection 2023 Dec.
9
Resident Synovial Macrophages in Synovial Fluid: Implications for Immunoregulation in Infectious and Inflammatory Arthritis.滑液中的常驻滑膜巨噬细胞:对感染性和炎症性关节炎免疫调节的影响
bioRxiv. 2024 Feb 25:2023.09.29.560183. doi: 10.1101/2023.09.29.560183.
10
Tissue inhibitors of metalloproteinases are proteolytic targets of matrix metalloproteinase 9.组织金属蛋白酶抑制剂是基质金属蛋白酶 9 的蛋白水解靶标。
Matrix Biol. 2023 Nov;123:59-70. doi: 10.1016/j.matbio.2023.09.002. Epub 2023 Oct 6.
新型冠状病毒肺炎中的细胞因子风暴:现有证据与治疗策略。
Front Immunol. 2020 Jul 10;11:1708. doi: 10.3389/fimmu.2020.01708. eCollection 2020.
4
Matrix metallopeptidase 9 as a host protein target of chloroquine and melatonin for immunoregulation in COVID-19: A network-based meta-analysis.基质金属蛋白酶 9 作为氯喹和褪黑素在 COVID-19 中免疫调节的宿主蛋白靶标:基于网络的荟萃分析。
Life Sci. 2020 Sep 15;257:118096. doi: 10.1016/j.lfs.2020.118096. Epub 2020 Jul 15.
5
Distinct and early increase in circulating MMP-9 in COVID-19 patients with respiratory failure.呼吸衰竭的COVID-19患者循环中的基质金属蛋白酶-9(MMP-9)出现明显且早期升高。
J Infect. 2020 Sep;81(3):e41-e43. doi: 10.1016/j.jinf.2020.06.061. Epub 2020 Jun 27.
6
Homotrimeric MMP-9 is an active hitchhiker on alpha-2-macroglobulin partially escaping protease inhibition and internalization through LRP-1.三聚体 MMP-9 是一种可主动搭乘的“顺风车”,它与α2-巨球蛋白结合后部分逃避了蛋白酶抑制和通过 LRP-1 的内化作用。
Cell Mol Life Sci. 2020 Aug;77(15):3013-3026. doi: 10.1007/s00018-019-03338-4. Epub 2019 Oct 23.
7
Matrix metalloproteinase-9 deficiency protects mice from severe influenza A viral infection.基质金属蛋白酶-9 缺乏可保护小鼠免受严重甲型流感病毒感染。
JCI Insight. 2018 Dec 20;3(24):99022. doi: 10.1172/jci.insight.99022.
8
Inhibitors of protein-protein interactions (PPIs): an analysis of scaffold choices and buried surface area.蛋白质-蛋白质相互作用(PPIs)抑制剂:支架选择和埋藏表面积分析。
Curr Opin Chem Biol. 2018 Jun;44:75-86. doi: 10.1016/j.cbpa.2018.06.004. Epub 2018 Jun 13.
9
Pharmacological targeting of plasmin prevents lethality in a murine model of macrophage activation syndrome.靶向纤溶酶可预防巨噬细胞活化综合征小鼠模型的致死性。
Blood. 2017 Jul 6;130(1):59-72. doi: 10.1182/blood-2016-09-738096. Epub 2017 Mar 21.
10
Glycosylation of matrix metalloproteases and tissue inhibitors: present state, challenges and opportunities.基质金属蛋白酶和组织抑制剂的糖基化:现状、挑战与机遇
Biochem J. 2016 Jun 1;473(11):1471-82. doi: 10.1042/BJ20151154.